1. Home
  2. > Pharmaceutical
  3. > OTC Market Trends
Global Inhalation and Nasal Spray Generic Drugs Market Size, Share & Industry Trends Analysis Report By End-user, By Indication, By Distribution Channel, By Demographics, By Regional Outlook and Forecast, 2022 – 2028

Global Inhalation and Nasal Spray Generic Drugs Market Size, Share & Industry Trends Analysis Report By End-user, By Indication, By Distribution Channel, By Demographics, By Regional Outlook and Forecast, 2022 – 2028

  • August 2022
  • 332 pages
  • ID: 6322090
  • Format: PDF
  • KBV Research

Summary

Table of Contents

The Global Inhalation and Nasal Spray Generic Drugs Market size is expected to reach $29.9 billion by 2028, rising at a market growth of 8.5% CAGR during the forecast period.

Inhalation and nasal spray generic drugs refer to a family of medicines that are consumed through the nose. For example, children who have asthma can use nebulizers and inhalers to take their medications. Most asthma medications start out as liquids. They need to be inhaled into the lungs in order to function. Children can breathe in liquid medication by using nebulizers and inhalers, which transform it into a mist. Some inhalers disperse the medication in a fine powder that can be inhaled as well. When used correctly, these medicines are very effective.

A tool used to provide medication in the form of a spray that is inhaled through the mouth or nose. Inhalers are commonly used to address conditions like asthma, emphysema, bronchitis, and angina. Additionally, they are employed to assist in the relief of withdrawal symptoms in smokers. There are two types of nasal spray viz a conventional spray and a pump spray.

It is crucial to utilize these products properly. This ensures that the medication is administered appropriately so that the body can absorb it. The nasal spray is a convenient way to administer a variety of drugs. The majority of these drugs are used to address issues with the nose and sinuses, like nasal congestion. Nasal sprays can be purchased without a prescription or over-the-counter. Nasal sprays target inflammation in the nasal passages, which lessens swelling and aids in clearing out stuffiness, to put it simply.

COVID-19 Impact Analysis

Nearly every business has been impacted by the public health emergency known as COVID-19. To ensure the incorporation of underlying COVID-19 problems and prospective future directions, the analyst’s continual research strengthens their research framework. There is a number of factors that impacted the inhalation and nasal spray generic drugs market, including changes in consumer demand and behavior, purchasing patterns, supply chain rerouting, dynamics of contemporary market forces, and significant government initiatives. The generic inhalation and nasal spray drugs market has benefited from the COVID-19 outbreak.

Market Growth Factors

Increasing Efforts of Government and Market Players

As the incidence of severe breathing and other disorders is rising all over the world, the demand for more effective and efficient drugs to treat such ailments is also expediting. Various major market players in the industry are increasing their efforts in order to treat these diseases. In recent years, the development of novel medications for respiratory diseases has provided an important boost. In order to treat a range of respiratory ailments, pharma producers are shifting away from traditional drug formulations and toward the development of better, more affordable drugs.

A Rapid Rise in The Cases Of Asthma All Over The World

A chronic illness that affects both children and adults is asthma. Due to inflammation and muscle stiffness around the tiny airways, the airways in the lungs become more restricted. Asthma symptoms including coughing, wheezing, shortness of breath, and tightness in the chest are brought on by this. These sensations come and go and are frequently worst at night or after exercise. Asthma symptoms can deteriorate due to other common factors.

Market restraining Factors

Challenges in Complying With Stringent Government Guidelines

In the context of health and medication, authenticity and quality are very crucial. However, as the number of market players is increasing all over the world in the sector of inhalation and nasal spray generic drugs, the concerns about public health are increasing. Concern regarding the quality of new medications entering the market grows when these therapies are produced at faster rates. Government quality control initiatives, where growing economies are trying to crack down with stricter laws and standards for generic drugs in response to increasing drug output, maybe partly hinder generic manufacturers’ expansion.

End-User Outlook

On the basis of End-Use, the Inhalation and Nasal Spray Generic Drugs Market is divided into Hospitals, Homecare, and Others. In 2021, the homecare segment registered the highest revenue share of the inhalation and nasal spray generic drugs market. The growth of the segment is substantially propelled due to favorable reimbursement rules and an increasingly older population. Respiratory problems are managed at patients’ homes and home healthcare centers as part of home care. Patients can now utilize inhalers and nasal sprays in their homes without the help of medical personnel because of growing healthcare knowledge and technological advancements.

Drug Class Outlook

Based on the Drug Class, the Inhalation and Nasal Spray Generic Drugs Market is segregated into Bronchodilators, Combination Drugs, Corticosteroids, Decongestant Sprays, Antihistamines, and Others. In 2021, the combination drugs garnered a significant revenue share of the inhalation and nasal spray generic drugs market. The introduction of combination medications by major manufacturers like Apotex Inc. and Teva Pharmaceutical majorly is credited with this growth. For instance, in March 2020, Apotex Inc. introduced a generic version of Dymista, a nasal spray used to treat allergic rhinitis that combines the medications azelastine and fluticasone.

Indication Outlook

Based on Indication, the Inhalation and Nasal Spray Generic Drugs Market is segmented into Asthma, Chronic Obstructive Pulmonary Disease (COPD), Allergic Rhinitis, and Others. In 2021, the asthma segment witnessed the highest revenue share of the inhalation and nasal spray generic drugs market. Due to the rising prevalence of asthma attacks in both children and adults, the demand for inhalers is rising to address asthma. Moreover, an increasing amount of pollution in the air people are inhaling these days is also a major factor that is considerably contributing to the rising growth of this segment.

Demographic Outlook

By Demographics, the Inhalation and Nasal Spray Generic Drugs Market is classified into Geriatric Patient, Adult Patient, and Pediatric Patient. In 2021, the adult patient segment recorded the largest revenue share of the inhalation and nasal spray generic drugs market. The primary driver of the segment’s growth is the increase in adult patients with COPD and asthma. Due to the rapidly evolving lifestyle of people all over the world, these diseases and disorders are more tend to occur as the age of people increases.

Distribution Channel Outlook

By Distribution Channel, the Inhalation and Nasal Spray Generic Drugs Market is categorized into Hospitals Pharmacy, Retail Pharmacy, and Online Pharmacies. In 2021, the online pharmacy segment garnered a significant revenue share of the inhalation and nasal spray generic drugs market. Patients can access online pharmacies easily and conveniently. The number of consumers buying products from online pharmacies is quickly rising as internet usage increases.

Regional Outlook

Region-Wise, the Inhalation and Nasal Spray Generic Drugs Market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. In 2021, North America held the largest revenue share of the inhalation and nasal spray generic drugs market. The main drivers of regional growth include the introduction of new goods, partnerships, acquisitions, and an increase in the prevalence of chronic respiratory disorders. The incidence of chronic obstructive pulmonary disease (COPD) in the United States is constantly rising in both men as well as women. The introduction of generic nasal sprays is anticipated to drive market expansion.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Viatris, Inc., Akorn, Operating Company LLC, Cipla Limited, Teva Pharmaceuticals Industries Ltd., Novartis AG (Sandoz International GmBH), Apotex, Inc., Hikma Pharmaceuticals PLC, Sun Pharmaceuticals Industries Ltd., Beximco Pharmaceuticals Ltd.

Scope of the Study

Market Segments covered in the Report:

By End-user

• Homecare

• Hospitals

• Others

By Drugs Class

• Bronchodilators

• Combination Drugs

• Antihistamines

• Corticosteroids

• Decongestant Sprays

• Others

By Indication

• Asthma

• Chronic Obstructive Pulmonary Disease (COPD)

• Allergic Rhinitis

• Others

By Distribution Channel

• Retail Pharmacy

• Hospitals Pharmacy

• Online Pharmacies

By Demographics

• Adult Patient

• Geriatric Patient

• Pediatric Patient

By Geography

• North America

o US

o Canada

o Mexico

o Rest of North America

• Europe

o Germany

o UK

o France

o Russia

o Spain

o Italy

o Rest of Europe

• Asia Pacific

o China

o Japan

o India

o South Korea

o Singapore

o Malaysia

o Rest of Asia Pacific

• LAMEA

o Brazil

o Argentina

o UAE

o Saudi Arabia

o South Africa

o Nigeria

o Rest of LAMEA

Companies Profiled

• Viatris, Inc.

• Akorn, Operating Company LLC

• Cipla Limited

• Teva Pharmaceuticals Industries Ltd.

• Novartis AG (Sandoz International GmBH)

• Apotex, Inc.

• Hikma Pharmaceuticals PLC

• Sun Pharmaceuticals Industries Ltd.

• Beximco Pharmaceuticals Ltd.

Unique Offerings

• Exhaustive coverage

• Highest number of market tables and figures

• Subscription based model available

• Guaranteed best price

• Assured post sales research support with 10% customization free

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Grace helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Inhalation & Nasal Sprays Generic Drugs Market Research Report by Indication, Age Group, Class, Route, Distrubution Channel, Country - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - North America Forecast 2023-2030

  • $ 3949
  • January 2023
  • 146 pages

Inhalation & Nasal Sprays Generic Drugs Market Research Report by Indication (Allergic Rhinitis, Asthma, and COPD), Age Group, Class, Route, Distrubution Channel, Country - Cumulative Impact of COVID-19, ...

  • North America
  • Cough And Cold
  • Nasal Drug Delivery
  • Industry analysis
  • Generic Drugs Market Share

Global Desmopressin Industry $ 5600 October 2022


ref:plp2022

Reportlinker.com © Copyright 2023. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on